Related references
Note: Only part of the references are listed.DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis
Jee-Heun Kim et al.
THERANOSTICS (2022)
Hypoxia effects on cancer stem cell phenotype in colorectal cancer: a mini-review
Mateus de Almeida Rainho et al.
MOLECULAR BIOLOGY REPORTS (2021)
Coronavirus Activates an Altruistic Stem Cell-Mediated Defense Mechanism that Reactivates Dormant Tuberculosis Implications in Coronavirus Disease 2019 Pandemic
Lekhika Pathak et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Tumour Microenvironment Stress Promotes the Development of Drug Resistance
Nicole A. Seebacher et al.
ANTIOXIDANTS (2021)
Cancer stem cell characteristics and their potential as therapeutic targets
Jacqueline R. Lim et al.
MEDICAL ONCOLOGY (2021)
MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model
Nina M. G. P. de Queiroz et al.
SCIENTIFIC REPORTS (2021)
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents
He-Ming Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma
Minjie Gao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update
Joseph A. Clara et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Lung adenocarcinoma resistance to therapy with EGFR-tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG
Fang Hu et al.
ONCOLOGY REPORTS (2020)
Cancer Stem Cells: Devil or Savior-Looking behind the Scenes of Immunotherapy Failure
Lorenzo Castagnoli et al.
CELLS (2020)
Hypoxia, Inflammation and Necrosis as Determinants of Glioblastoma Cancer Stem Cells Progression
Marco Papale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Plasma membrane damage causes NLRP3 activation and pyroptosis during Mycobacterium tuberculosis infection
Kai S. Beckwith et al.
NATURE COMMUNICATIONS (2020)
MYC Regulates the HIF2α Stemness Pathway via Nanog and Sox2 to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells
Bikul Das et al.
CANCER RESEARCH (2019)
Hypoxia induced cancer stem cell enrichment promotes resistance to androgen deprivation therapy in prostate cancer
Debbie O'Reilly et al.
STEROIDS (2019)
Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma
Chengsheng Wu et al.
BMC CANCER (2018)
Stemness and anti-cancer drug resistance in ATP-binding cassette subfamily G member 2 highly expressed pancreatic cancer is induced in 3D culture conditions
Norihiko Sasaki et al.
CANCER SCIENCE (2018)
Caspase-1-dependent pyroptosis of peripheral blood mononuclear cells predicts the development of sepsis in severe trauma patients A prospective observational study
Yu-chang Wang et al.
MEDICINE (2018)
Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
Sara R. Martins-Neves et al.
PHARMACOLOGICAL RESEARCH (2018)
Cancer stem cells as key drivers of tumour progression
Ain Zubaidah Ayob et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells
Hoon Kim et al.
BREAST CANCER RESEARCH (2018)
The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma
Qian Zhong et al.
CLINICAL CANCER RESEARCH (2018)
Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors
Carolina Mendez-Blanco et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Drug Resistance Driven by Cancer Stem Cells and Their Niche
Marta Prieto-Vila et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
Guan-Zhong Qiu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment
Pedro M. Aponte et al.
STEM CELLS INTERNATIONAL (2017)
Intravesical BCG InducesCD4+ T-Cell Expansion in an Immune Competent Model of Bladder Cancer
Max Kates et al.
CANCER IMMUNOLOGY RESEARCH (2017)
In vitro Culture of Naive Human Bone Marrow Mesenchymal Stem Cells: A Stemness Based Approach
Bidisha Pal et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2017)
Targeting oral cancer stem cells in the hypoxic niche by BCG infected mesenchymal stem cells
Bidisha Pal et al.
CANCER RESEARCH (2017)
Human embryonic stem cells exhibit altruistic cell death that release death signals having potent anti-cancer activity
Bidisha Pal et al.
CANCER RESEARCH (2017)
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Amancio Carnero et al.
BIOESSAYS (2016)
Chemotherapy induces sternness in osteosarcoma cells through activation of Wnt/β-catenin signaling
Sara R. Martins-Neves et al.
CANCER LETTERS (2016)
Migratory cancer side population cells induces stem cell altruism in bone marrow mesenchymal stem cells to resist therapy, and enhance tumorigenic potential of non-tumorigenic cells
Joyeeta Talukdar et al.
CANCER RESEARCH (2016)
Oral cancer cells may hijack stem cell altruism to survive during extreme hypoxia, and exposure to chemotherapeutic drugs
Rashmi Bhuyan et al.
CANCER RESEARCH (2016)
Cancer stem cells Role in tumor growth, recurrence, metastasis, and treatment resistance
Jenny C. Chang
MEDICINE (2016)
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance
Peyman Ranji et al.
TUMOR BIOLOGY (2016)
Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy
Xiaoyun Dai et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation
Dah-Shyong Yu et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2015)
HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation
Jiliang Yan et al.
ONCOLOGY REPORTS (2015)
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
Twan van den Beucken et al.
NATURE COMMUNICATIONS (2014)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
TLR agonists: our best frenemy in cancer immunotherapy
Sabina Kaczanowska et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model
Lotfi Abou-Elkacem et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Roles of toll-like receptors in Cancer: A double-edged sword for defense and offense
Shaherin Basith et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
Chung-Gi Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
p53/HMGB1 Complexes Regulate Autophagy and Apoptosis
Kristen M. Livesey et al.
CANCER RESEARCH (2012)
Induction of cancer cell stemness by chemotherapy
Xingwang Hu et al.
CELL CYCLE (2012)
HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells
Clarissa Anni Wild et al.
INTERNATIONAL IMMUNOLOGY (2012)
Targeting pediatric cancer stem cells with oncolytic virotherapy
Gregory K. Friedman et al.
PEDIATRIC RESEARCH (2012)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
HIF-2α Suppresses p53 to Enhance the Stemness and Regenerative Potential of Human Embryonic Stem Cells
Bikul Das et al.
STEM CELLS (2012)
HMGB1-Facilitated p53 DNA Binding Occurs via HMG-Box/p53 Transactivation Domain Interaction, Regulated by the Acidic Tail
John P. Rowell et al.
STRUCTURE (2012)
Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development
K. Moitra et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
The p53 Pathway as a Target in Cancer Therapeutics: Obstacles and Promise
Anna Mandinova et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Role of Oxidative Stress in Stem, Cancer, and Cancer Stem Cells
Ahmed Abdal Dayem et al.
Cancers (2010)
Mycobacterium bovis Bacillus Calmette-Guerin Infection Induces TLR2-Dependent Peroxisome Proliferator-Activated Receptor γ Expression and Activation: Functions in Inflammation, Lipid Metabolism, and Pathogenesis
Patricia E. Almeida et al.
JOURNAL OF IMMUNOLOGY (2009)
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Michael Dean
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy?
Elias Jabbour et al.
MAYO CLINIC PROCEEDINGS (2009)
Cell death in the host response to infection
K. Labbe et al.
CELL DEATH AND DIFFERENTIATION (2008)
Stem cell regulation and host defense: The logic and the paradox
Goran Karlsson et al.
CELL STEM CELL (2008)
Cisplatin treatment increases survival and expansion of a highly tumorigenic side-population fraction by upregulating VEGF/Flt1 autocrine signaling
R. Tsuchida et al.
ONCOGENE (2008)
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction
Bikul Das et al.
STEM CELLS (2008)
Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth
Bikul Das et al.
NEOPLASIA (2008)
Bystander macrophage apoptosis after Mycobacterium tuberculosis H37Ra infection
Deirdre M. Kelly et al.
INFECTION AND IMMUNITY (2008)
Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity
H Husebye et al.
EMBO JOURNAL (2006)
Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic
L Patrawala et al.
CANCER RESEARCH (2005)
Share Paper
